Dosage Forms & Drug Delivery Systems – Page 8

Hold Time Bioburden Rise during method transfer: water system and sanitation checks

Recognizing symptoms early is crucial in addressing any rise in bioburden during method transfer. Key signals may include:Click to read the full article.

Crystallization In Syrup in oral suspension manufacturing: mixing, sampling, and hold-time controls

Identifying symptoms of crystallization is crucial in a timely manner. Key indicators may include:Click to read the full article.

Hold Time Bioburden Rise during method transfer: mixing, sampling, and hold-time controls

Identifying high bioburden levels during hold time is critical for maintaining product quality. Symptoms can vary but generally reveal themselves through multiple signals on the manufacturing floor or within quality…

Sedimentation Rate Oos at accelerated stability: mixing, sampling, and hold-time controls

Recognizing the signs indicative of potential sedimentation issues is the first step in proactive quality management. Symptoms on the production floor may manifest as:Click to read the full article.

Microbial Limits Failure during filling line setup: packaging and transport risk assessment

Recognizing symptoms or signals early in the filling line setup can significantly aid in identifying microbial limits failures. Common signals may include:Click to read the full article.

Sedimentation Rate Oos in oral suspension manufacturing: how QA should write CAPA for inspectors

The first indication of a potential issue is often a deviation signal that suggests the sedimentation rate of an oral suspension has surpassed acceptable limits. These symptoms may manifest through:Click…

Microbial Limits Failure after supplier change: mixing, sampling, and hold-time controls

Identifying symptoms or signals that indicate a microbial limits failure is pivotal for initiating a timely investigation. Common signals include:Click to read the full article.

Assay Oos in syrup production: manufacturing vs lab root cause decision tree

Detecting an assay OOS typically arises from several initial signs observed either on the manufacturing floor or during laboratory testing:Click to read the full article.

Color Change On Stability in oral suspension manufacturing: investigation flowchart aligned to GMP

Investigating Color Change in Stability of Oral Suspensions: A GMP-Compliant Approach In pharmaceutical manufacturing, especially with liquid formulations such as oral suspensions, any deviation from expected product characteristics can signal…

Phase Separation during EU/UK market supply: how QA should write CAPA for inspectors

The first step in addressing phase separation is to recognize the symptoms or signals that indicate a deviation from expected quality standards. Symptoms of phase separation may include:Click to read…

Preservative Under-Dosing in syrup production: manufacturing vs lab root cause decision tree

The first sign of preservative under-dosing could emerge from various symptoms or signals during the production process or quality control testing. Identifying these signals promptly can help in taking corrective…

Hold Time Bioburden Rise after supplier change: water system and sanitation checks

The first step in addressing a potential rise in hold time bioburden is to identify clear signals that indicate an issue. Symptoms may include:Click to read the full article.